Source: Biospectrum Asia

Sanofi Pasteur: Sanofi evaluates impact and prevention of influenza at 'Options X'

Flu which can lead to pneumonia, heart attack and stroke is now preventable through Flublok®, the first recombinant Influenza Vaccine and Fluzone® High-Dose Vaccine (IIV3-HD)

Read full article »
Est. Annual Revenue
$5.0-10B
Est. Employees
10-50K
Olivier Brandicourt's photo - CEO of Sanofi Pasteur

CEO

Olivier Brandicourt

CEO Approval Rating

68/100

Read more